Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-26 @ 12:06 PM
Study NCT ID:
NCT05915351
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-16
First Post:
2023-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
Sponsor:
University of Kansas Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-23
First Submit QC Date:
None
Study First Post Date:
2023-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-11
Last Update Post Date:
2025-04-16
Last Update Post Date Type:
ACTUAL